REGENXBIO
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Maryland, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
9804 Medical Center Dr, Rockville, Maryl...Phone Number
(240) 552-8181Website
www.regenxbio.comRevenue
$87.8 MillionStock Symbol
RGNXIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
4
3
1
1
2
About REGENXBIO
REGENXBIO Inc. is a clinical-stage biotechnology company. It specializes in providing gene therapy product. The company was founded in 2008 and is headquartered in Rockville, Maryland.Explore more
REGENXBIO Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is REGENXBIO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if REGENXBIO had a recent Job posting/layoffs
REGENXBIO, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at REGENXBIO
Earning: See what the market has to say on REGENXBIO recently announced quarterly report
Funding: Get notified immidiatlly once REGENXBIO has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if REGENXBIO has recently received funding, and reach out quickly before it becomes old news!
Check out if REGENXBIO is spiking on competitors!
Product Launch: Get notified when REGENXBIO launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to REGENXBIO
Compare insights from companies similar to REGENXBIO, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
REGENXBIO is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
REGENXBIO is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about REGENXBIO.
REGENXBIO financials insights
Gather financial insights about REGENXBIO, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$138.6M
REGENXBIO Tech Stack
A closer look at the technologies used by REGENXBIO
See more technologies
Most Recent Scoops
Person-Based
Medical Research, Pharmaceuticals
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Product Development, Pharmaceuticals
Person-Based
Pharmaceuticals, Regulations
REGENXBIO News & Media
REGENXBIO Announces Proposed Public Offering of Common Stock
ROCKVILLE, Md., July 16, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it intends to offer and sell, subject to market conditions, $100 million of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and...REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone
New long-term data from diabetic retinopathy and wet AMD programs to be presented at American Society of Retina Specialists (ASRS) 2026 ROCKVILLE, Md., June 29, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the first patient has been dosed in the Phase IIb/III...REGENXBIO Completes Dosing in Confirmatory Study of RGX-202, Marking Completion of Registrational Development Program and Supporting Planned BLA Submission in Q3 2026
Confirmatory study completed ahead of schedule due to strong patient demand and robust investigator interest On track to initiate BLA in Q3 2026 under the accelerated approval pathway supporting potential approval in 2H 2027 ROCKVILLE, Md., June 24, 2026 /PRNewswire/ -- REGENXBIO Inc....REGENXBIO Announces Alignment with FDA on Path Forward for NAVSUNLI™ BLA Resubmission for Accelerated Approval; First Potential Gene Therapy for MPS II
FDA confirmed no additional studies required, existing longer-term data from the CAMPSIITE® study will be reviewed on an expedited basis for approval via the accelerated approval pathway The Company expects to resubmit the BLA in Q3 2026 ROCKVILLE, Md., June 22, 2026 /PRNewswire/ --...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding REGENXBIO
Sign Up For FreeTo access detailed company insights
REGENXBIO Inc. is a clinical-stage biotechnology company. It specializes in providing gene therapy product. The company was founded in 2008 and is headquartered in Rockville, Maryland.... Read More
